The Relation Between Regular Outpatient Follow-up and Frequency of Emergency Department Visits in Sickle Cell Pediatric Patients

Overview

Journal Saudi Med J

Specialty General Medicine

Date 2020 Dec 9

PMID 33294890

Citations 4

Authors

Abeer F Ismail

Raghad A Tarawah

Zainab Y Azzouni

Lojain T Alharbi

Raghad M Altayyar

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the relationship between the frequency of ED visits and outpatient department (OPD) follow-up in sickle cell disease (SCD) pediatric patients.

Methods: A retrospective cohort study included 247 SCD pediatric patients between January 2016 and December 2018 at the Maternity and Children Hospital, Department of Pediatrics, Al Medinah Al Munawarah, Saudi Arabia. Data were extracted from electronic medical record system; patient demographics, medications, frequency of emergency department (ED) and OPD visits. Pearson correlation coefficient, linear regression and independent sample t-test were applied.

Results: There was no significant correlation (95% CI [-0.013- 0.233]; p=0.07) between the frequency of ED and OPD visits. However, a significant correlation was found between ED visits and missed OPD appointments. Thus, linear regression was applied and indicated that one missed OPD appointment is associated with 1.92 ED visits, (95% CI: 0.19-0.42; p less than 0.001). Also, a higher rate of ED visits was observed when compared with other studies, with a high ED reliance of 43%.

Conclusion: This study found that regular OPD visits could improve SCD management, as a directly proportional relationship between the frequency of ED visits and missed OPD appointments along with high ED reliance.

Citing Articles

Outcome of Pediatric Patients With Sickle Cell Anemia Admitted With Fever: A Retrospective Single-Center Study.

Zolaly M, Alharbi A, Algrafi S, Balkhair M, Aljohani J, Quordi M Cureus. 2024; 16(9):e69570.

PMID: 39421130 PMC: 11483867. DOI: 10.7759/cureus.69570.

Gaps during pediatric to adult care transfer escalate acute resource utilization in sickle cell disease.

Howell K, Kayle M, Smeltzer M, Nolan V, Mathias J, Nelson M Blood Adv. 2024; 8(14):3679-3685.

PMID: 38809136 PMC: 11284702. DOI: 10.1182/bloodadvances.2023011268.

The Health Belief Model Modifying Factors Associated with Missed Clinic Appointments among Individuals with Sickle Cell Disease in the Jazan Province, Saudi Arabia.

Alhazmi S, Maashi A, Shabaan S, Majrashi A, Thakir M, Almetahr S Healthcare (Basel). 2022; 10(12).

PMID: 36553900 PMC: 9778402. DOI: 10.3390/healthcare10122376.

Treatment Options That Reduce the Duration of Sickle Cell Vaso-Occlusive Crises: A Systematic Review.

Akindele A, Jalkh A, Eastmond A, Shetty C, Rizvi S, Sharaf J Cureus. 2022; 14(8):e28337.

PMID: 36176876 PMC: 9510888. DOI: 10.7759/cureus.28337.

References

Keikhaei B, Yousefi H, Bahadoram M . Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia. Glob J Health Sci. 2015; 8(3):252-6. PMC: 4803938. DOI: 10.5539/gjhs.v8n3p252. View

Morgan S, Chang A, Alqatari M, Pines J . Non-emergency department interventions to reduce ED utilization: a systematic review. Acad Emerg Med. 2013; 20(10):969-85. PMC: 4038086. DOI: 10.1111/acem.12219. View

Kroner E, Hoffmann R, Brousseau D . Emergency department reliance: a discriminatory measure of frequent emergency department users. Pediatrics. 2009; 125(1):133-8. DOI: 10.1542/peds.2009-0960. View

Alsaeed E, Farhat G, Assiri A, Memish Z, Ahmed E, Saeedi M . Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011-2015. J Epidemiol Glob Health. 2018; 7 Suppl 1:S41-S47. PMC: 7386442. DOI: 10.1016/j.jegh.2017.12.001. View

Nietert P, Silverstein M, Abboud M . Sickle cell anaemia: epidemiology and cost of illness. Pharmacoeconomics. 2002; 20(6):357-66. DOI: 10.2165/00019053-200220060-00001. View

Blinder M, Duh M, Sasane M, Trahey A, Paley C, Vekeman F . Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease. J Emerg Med. 2015; 49(4):513-522.e1. DOI: 10.1016/j.jemermed.2014.12.080. View

Schlichting L, Rogers M, Gjelsvik A, Linakis J, Vivier P . Pediatric Emergency Department Utilization and Reliance by Insurance Coverage in the United States. Acad Emerg Med. 2017; 24(12):1483-1490. DOI: 10.1111/acem.13281. View

Al-Faris E, Abdulghani H, Mahdi A, Salih M, Al-Kordi A . Compliance with appointments and medications in a pediatric neurology clinic at a University Hospital in Riyadh, Saudi Arabia. Saudi Med J. 2002; 23(8):969-74. View

Christakis D, Wright J, Koepsell T, Emerson S, Connell F . Is greater continuity of care associated with less emergency department utilization?. Pediatrics. 1999; 103(4 Pt 1):738-42. DOI: 10.1542/peds.103.4.738. View

10.

Nguyen G, Lewis A, Goldener C, Reed B, Dulman R, Yang E . Discontinuation of Folic Acid Supplementation in Young Patients With Sickle Cell Anemia. J Pediatr Hematol Oncol. 2016; 39(6):470-472. DOI: 10.1097/MPH.0000000000000675. View

11.

Alotaibi M . Sickle cell disease in Saudi Arabia: A challenge or not. J Epidemiol Glob Health. 2017; 7(2):99-101. PMC: 7320430. DOI: 10.1016/j.jegh.2016.12.006. View

12.

Kauf T, Coates T, Huazhi L, Mody-Patel N, Hartzema A . The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009; 84(6):323-7. DOI: 10.1002/ajh.21408. View

13.

Hemker B, Brousseau D, Yan K, Hoffmann R, Panepinto J . When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department. Am J Hematol. 2011; 86(10):863-5. DOI: 10.1002/ajh.22106. View

14.

Leschke J, Panepinto J, Nimmer M, Hoffmann R, Yan K, Brousseau D . Outpatient follow-up and rehospitalizations for sickle cell disease patients. Pediatr Blood Cancer. 2011; 58(3):406-9. DOI: 10.1002/pbc.23140. View

15.

Badawy S, Thompson A, Holl J, Penedo F, Liem R . Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease. Pediatr Hematol Oncol. 2019; 35(5-6):297-308. DOI: 10.1080/08880018.2018.1505988. View

16.

Al-Qurashi M, El-Mouzan M, Al-Herbish A, Al-Salloum A, Al-Omar A . The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey. Saudi Med J. 2008; 29(10):1480-3. View

17.

Candrilli S, OBrien S, Ware R, Nahata M, Seiber E, Balkrishnan R . Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol. 2011; 86(3):273-7. DOI: 10.1002/ajh.21968. View

18.

Rabb L, Grandison Y, Mason K, Hayes R, Serjeant B, Serjeant G . A trial of folate supplementation in children with homozygous sickle cell disease. Br J Haematol. 1983; 54(4):589-94. DOI: 10.1111/j.1365-2141.1983.tb02138.x. View

19.

McGann P, Ware R . Hydroxyurea therapy for sickle cell anemia. Expert Opin Drug Saf. 2015; 14(11):1749-58. PMC: 5868345. DOI: 10.1517/14740338.2015.1088827. View

20.

Brousseau D, Owens P, Mosso A, Panepinto J, Steiner C . Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010; 303(13):1288-94. DOI: 10.1001/jama.2010.378. View